Work

Emapalumab as a Life-Saving Therapy for Macrophage Activation Syndrome in Refractory Systemic Juvenile Idiopathic Arthritis with Trisomy 21

Year: 2025

Type: article

Abstract: Cite this article as: Akay N, Aslan E, Gul U, Konte EK, Yildiz M, Sahin S. Emapalumab as a life-saving therapy for macrophage activation syndrome in refractory systemic juvenile idiopathic arthritis with trisomy 21. Turk Arch Pediatr. 2025;60(6):695-699.

Source: Turkish Archives of Pediatrics

DOI: 10.5152/turkarchpediatr.2025.25394

Authors: Nergis Akay, Ece Aslan, Umit Gul, Elif Kilic Konte, Mehmet Yildiz, Sezgin Sahin

Institutions: Istanbul University-Cerrahpaşa, Istanbul University

Language: English

Topic: Autoimmune and Inflammatory Disorders Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4415873314

FWCI:

Cites:

Cited by:

Related to: